B

Braveheart Bio

Develops cardiac myosin inhibitors for HCM

Director/Senior Director - Clinical Quality

Regulatory & Quality (Life Sciences)Posted on Nov 6
Full-timeSan Francisco, CA, USAIn-person

About the Job

Requirements

  • A bachelor's degree in life sciences, nursing, or a related discipline is required; an advanced degree is preferred.
  • At least 10 years of GCP quality experience, including deep experience in GCP oversight, global clinical development, and late-stage development.
  • Strong knowledge of global GxP regulations, including GCP, GLP, GVP, and GDP as applicable, and regulatory expectations for late-stage clinical programs.
  • Ability to assess risk, solve complex problems, and implement practical, scalable quality solutions.
  • Proven success establishing and executing clinical oversight in a small or emerging biotechnology environment.
  • Experience developing quality oversight strategies, overseeing vendors and CROs, and supporting inspection readiness and regulatory interactions.
  • Demonstrated expertise in GDPR and clinical data-privacy compliance.
  • Demonstrated experience with computerized system validation for clinical systems in a regulated environment.
  • Strong written and verbal communication skills with a collaborative, team-oriented approach.
  • Ability to thrive in a fast-paced, dynamic environment and remain comfortable with change and ambiguity.
  • Flexible, proactive, hands-on approach.

Responsibilities

  • Lead clinical quality strategy aligned with global regulatory requirements, risk-based quality principles, and business priorities.
  • Establish fit-for-purpose quality practices that support late-stage development and inspection readiness.
  • Serve as a quality partner to clinical teams, proactively identifying, assessing, and mitigating risk.
  • Drive continuous improvement to strengthen quality culture, streamline execution, and improve compliance effectiveness.
  • Serve as the company’s GCP subject matter expert and provide quality guidance across clinical development activities.
  • Lead risk-based quality oversight of CROs, vendors, clinical laboratories, and clinical sites.
  • Direct GCP inspection readiness activities and serve as a key quality leader during health authority inspections.
  • Support computerized system validation for clinical systems used at clinical vendors, including oversight of validation activities and review of validation documentation.
  • Develop and maintain clinical quality study oversight plans.
  • Collaborate with Quality Compliance and Risk Management to develop inspection readiness strategies.
  • Lead clinical deviation investigations, root cause analysis, and CAPA management related to clinical activities.
  • Ensure timely and effective resolution of quality issues and maintain inspection readiness across clinical activities, documentation, and teams.
  • Collaborate with Legal on implementation and management of GDPR and data privacy requirements.
  • Support GDPR and data privacy compliance.
  • Partner with Data Management, IT, Legal, and vendors to ensure appropriate handling, storage, and transfer of personal data.
  • Support data protection impact assessments, vendor privacy assessments, and data processing agreements.
  • Collaborate with and provide quality support to Clinical Operations, Biometrics, Pharmacovigilance, Medical/Clinical Development, Medical Affairs, Nonclinical, and other groups as needed, embedding quality expectations into study planning, startup, execution, and closeout.
  • Participate in project team meetings and cross-functional planning to integrate quality considerations into decision-making.
  • Provide ad hoc quality support across broader GxP activities as business needs evolve.
  • Contribute to cross-functional quality initiatives, inspections, and issue resolution.
  • May build and lead a small quality team as the company grows.

Desired Qualifications

  • Experience in rare disease, cardiovascular, or specialty-disease clinical development.
  • Experience supporting preparation for major regulatory submissions, including NDA, BLA, or MAA.
  • Prior experience with data privacy frameworks beyond GDPR, such as CCPA.
  • Audit certification or quality certification, such as ASQ.
  • Experience with GLP, including 21 CFR Part 58 and OECD.

About the Company

Braveheart Bio

Develops cardiac myosin inhibitors for HCM

Braveheart Bio develops therapies for hypertrophic cardiomyopathy by in-licensing promising drug candidates and advancing them through late-stage clinical trials. Its lead drug, BHB-1893, is a selective small-molecule cardiac myosin inhibitor licensed from Hengrui Pharma for ex-China rights, designed to reduce contractility in heart cells and improve heart performance. The company differentiates itself by pursuing a best-in-class profile with potential improvements in efficacy, safety, and dosing, supported by a high-profile leadership team and investors. Its goal is to bring an approved, globally accessible therapy for HCM that delivers meaningful clinical benefit.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2025

Recently Posted Jobs

Explore more opportunities at Braveheart Bio

See more jobs